Neutron capture therapy is an attractive alternative to standard radiation techniques for cancer treatment, if nuclei such as 10B, can be selectively concentrated in tumors. Small, unilamellar phospholipids vesicles are known to be taken up by animal and human tumors. Liposome formulations will be tested for their ability to stably encapsulate high concentrations of boron compounds. Biodistribution of these B-containing liposomes will be tested in mice bearing EMT6 tumors using radioiodine-labeled Na2 B10 H10.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA044208-01
Application #
3491663
Study Section
(SSS)
Project Start
1987-06-01
Project End
1988-03-31
Budget Start
1987-06-01
Budget End
1988-03-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Nexstar Pharmaceuticals, Inc.
Department
Type
DUNS #
City
San Dimas
State
CA
Country
United States
Zip Code
91773